Welcome back to the “52 in 52” series. Post #26 looks at the EXACT trial and oxygen targets in the post-ROSC patient after OHCA.

What do you need to know about propranolol toxicity?

How should you evaluate and manage the patient with cardiogenic shock?

Journal Feed covers intra-articular lidocaine for shoulder reduction, improving CT yield for GI bleeding, and predictors of testicular torsion.

Today on the emDOCs cast, Brit Long, MD, interviews Sophia Gorgens, MD, on the evaluation and management of the drowning patient.

A 60-year-old female with diabetes and hypertension from skilled nursing facility presents with worsening mental status, shortness of breath, and muscle weakness. Vital signs include BP 175/100, HR 105, RR 22, SpO2 95% on room air, T 100.7F, and blood glucose of 275. Physical exam is remarkable for A&Ox2, obesity, striae, bilateral upper/lower extremity muscle weakness, and 2+ bilateral lower extremity edema. CMP/CBC is unremarkable, BNP is 250, and EKG shows low voltage. Outpatient random serum cortisol is 2700 nmol/L. What is the diagnosis, and urgent interventions will reduce the patient’s morbidity/mortality?

The 52 in 52 series returns with #25,w which looks at risk of major ischemic or hemorrhagic event with rivaroxaban versus apixaban. 

Policy Playbook returns with a summary of the latest developments in the current procedural terminology (CPT) changes.